GODAVARI Stock View

Godavari Drugs Ltd

GODAVARI Stock View

(BSE)

Trade

0.16 | 0.17

Market Cap ₹( Cr.)
695.37

Proj. P/E (x)

Proj. P/BV (x)

Proj. ROE (%)

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)

Last Updated On.
01-Oct-2023

 

Copy Link

Godavari Drugs Limited is an India-based company, which is engaged in the business of manufacturing application programming interfaces (API’s), drug intermediaries and fine chemicals. The Company also has active loan licenses and contract manufacturing tie-ups with multinational companies for API’s and drug intermediates. It serves the global life science industry. Its API products offering includes Ciprofloxacin HCl USP/EP/BP/IP, Ciprofloxacin (Base) USP/EP/BP/IP, Ciprofloxacin Lactate IH, Ciprofloxacin Betaine IH, Mefenamic Acid USP/EP/BP/IP, Enrofloxacin USP/EP/BP/IP and Elthambutoal HCI USP/BP/IP. Its intermediates include A D Lactone (for Spironolactone) and 6 Mercaptopurine (for Azathioprine). The Company's manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The facility has multiple production blocks for API’s, drug intermediates and fine chemicals.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data